Approach to the Patient with a Suspected Cutaneous Adverse Drug Reaction.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26476256.
- Also identified by DOI 10.1016/j.mcna.2015.06.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CADRs are common and generally have a mild, self-resolving course with minimal associated morbidity and mortality. However, subsets of CARDs are more severe, require intervention, and have significant risk of associated morbidity and mortality. For this reason, it is crucial that the clinician recognize signs and symptoms worrisome for a more severe CARD so that appropriate triage, work-up, and treatment are initiated. In all CADRs the most important first step is identification and withdrawal of the culprit medications.
Medical subject headings
- Drug Eruptions